Literature DB >> 2394696

Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence.

O Wiedow1, J M Schröder, H Gregory, J A Young, E Christophers.   

Abstract

A potent inhibitor of human leukocyte elastase (EC 3.4.21.37) and porcine pancreatic elastase (EC 3.4.21.36) was purified to homogeneity from human horny layers. It inhibits human leukocyte elastase and porcine pancreatic elastase in a 1:1 molar ratio and shows equilibrium dissociation constants of 6 x 10(-10) M and 1 x 10(-9) M, respectively. Inhibition of plasmin, trypsin, alpha-chymotrypsin, and cathepsin G was not observed. This inhibitor proved to be an acid stable basic peptide with an isoelectric point of 9.7. The complete amino acid sequence appears to be unique with 38% homology to the C-terminal half of antileukoprotease. The sequence shows that the inhibitor is composed of 57 amino acids and predicts a Mr of 7017. The high affinity as well as the apparent specificity for elastases suggests a functional role in preventing elastase-mediated tissue proteolysis. It is suggested that the term "elafin" be used to designate this inhibitor.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  83 in total

1.  Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor.

Authors:  E Remold-O'Donnell; J Chin; M Alberts
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

2.  A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein.

Authors:  Adam Clauss; Hans Lilja; Ake Lundwall
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

Review 3.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  Changes in keratinocyte differentiation following mild irritation by sodium dodecyl sulphate.

Authors:  M Le; J Schalkwijk; G Siegenthaler; P C van de Kerkhof; J H Veerkamp; P G van der Valk
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

Review 5.  Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors.

Authors:  B Dunbar; M Patel; J Fahey; C Wira
Journal:  Mol Cell Endocrinol       Date:  2012-01-25       Impact factor: 4.102

6.  Skin-derived antileukoproteinase (SKALP) is decreased in pustular forms of psoriasis. A clue to the pathogenesis of pustule formation?

Authors:  A L Kuijpers; P L Zeeuwen; G J de Jongh; P C van de Kerkhof; H A Alkemade; J Schalkwijk
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

7.  Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer.

Authors:  Yuanzhu Jiang; Chao Wang; Baoyu Lv; Guoyuan Ma; Lei Wang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

8.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

9.  Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.

Authors:  Keita Tokuishi; Shin-ichi Yamashita; Kazuyuki Ohbo; Katsunobu Kawahara
Journal:  Tumour Biol       Date:  2011-10-21

10.  Elafin, a serine elastase inhibitor, attenuates post-cardiac transplant coronary arteriopathy and reduces myocardial necrosis in rabbits afer heterotopic cardiac transplantation.

Authors:  B Cowan; O Baron; J Crack; C Coulber; G J Wilson; M Rabinovitch
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.